Table 1 Baseline characteristics of the patients with PTCL-NOS.

From: BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified

Patients (N = 27)

Number (%), median [range]

Age < 65 years

13 (48)

 ≥ 65 years

14 (52)

Female

9 (23)

Male

18 (67)

Stage I-III

14 (52)

IV

13 (48)

Previously untreated

11 (41)

Previously treated

16 (59)

Previous therapies < 2

16 (59)

 ≥ 2

11 (41)

No previous SCT

22 (81)

Previous SCT

5 (19)

No previous XRT

25 (93)

Previous XRT

2 (7)

Th1 phenotype

15 (56)

Th2 phenotype

10 (37)

Unclassified

2 (7)

MCL-1 (%)

70 [1–100]

BCL-W (%)

100 [40–100]

BCL-XL (%)

10 [0–90]

BCL-2A1 (%)

20 [0–90]

BCL-2 (%)

30 [1–100]

  1. SCT stem cell transplant, XRT radiotherapy, Th T helper.
Back to article page